Product NDC: | 60432-126 |
Proprietary Name: | Megestrol Acetate |
Non Proprietary Name: | Megestrol Acetate |
Active Ingredient(s): | 40 mg/mL & nbsp; Megestrol Acetate |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60432-126 |
Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076721 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050209 |
Package NDC: | 60432-126-08 |
Package Description: | 240 mL in 1 BOTTLE, PLASTIC (60432-126-08) |
NDC Code | 60432-126-08 |
Proprietary Name | Megestrol Acetate |
Package Description | 240 mL in 1 BOTTLE, PLASTIC (60432-126-08) |
Product NDC | 60432-126 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Megestrol Acetate |
Dosage Form Name | SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20050209 |
Marketing Category Name | ANDA |
Labeler Name | Morton Grove Pharmaceuticals, Inc. |
Substance Name | MEGESTROL ACETATE |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |